S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)

Are Dividend Aristocrats in Your Portfolio in 2022?

Tuesday, January 11, 2022 | Melissa Brock
Are Dividend Aristocrats in Your Portfolio in 2022?

Ready for some major dividend activity to go your way in 2022? Many investors turn to dividend income for a solid way to grow their portfolio and tap into a cash flow. You may especially want to consider this option if you want to use dividends to live off of in retirement.

Why not consider one (or several) of the Dividend Aristocrats, a fancy description for high-performing dividend stocks? 

Let's find out more about the Dividend Aristocrats and pick a handful for this year's go-round in the stock market.

What are the Dividend Aristocrats? 

First of all, if you're not completely squared away with the definition of dividends, it simply means that when a publicly-traded company generates profits it can direct the funds into research and development, save the money or return the profits to shareholders as dividends. As a shareholder, your goal is to reap the benefits of these dividends, whether you squirrel them away for use later on, reinvest them or spend them right away — you've gotta eat, right?

The Dividend Aristocrats simply refer to well-known companies that are part of the S&P 500 that pay dividends. The Dividend Aristocrats must possess a few distinct qualifications to qualify as part of this elite group. Each company must have:

  • Increased the annual total dividend per share for 25 straight years in a row.
  • A market capitalization of at least $3 billion.
  • A daily trading amount of at least $5 million. 

Here are a few companies that hit the bullseye for those requirements (but note that there are 65 Dividend Aristocrats, so this doesn't come close to the full list):

Three new additions to the family made the list in 2021: International Business Machines (IBM) (NYSE: IBM), NextEra Energy (NYSE: NEE), and West Pharmaceutical Services (NYSE: WST). Unfortunately, six companies got kicked out of the family: Raytheon (NYSE: RTX), Carrier Global (NYSE: CARR), Otis Worldwide (NYSE: OTIS), Church and Dwight (NYSE: CHD), Stryker Corporation (NYSE: SYK) and Leggett & Platt Inc. (NYSE: LEG).

Consider Adding The Following Dividend Aristocrats to Your Portfolio

Take a look at a few we've chosen for you to eyeball if your main goal is to have dividends at your disposal. Instead of the main biggies like Johnson & Johnson, Procter & Gamble, and other tried-and-true companies, we've tackled four Dividend Aristocrats that may not be on your radar.

Federal Realty Investment Trust (NYSE: FRT)

Federal Realty Investment Trust (NYSE: FRT), based in Maryland, is one of the most notable Dividend Aristocrats and real estate investment trusts (REITs). The company owns, operates, and develops retail and mixed-use neighborhoods in the northeastern United States, the mid-Atlantic states, California and South Florida. The company recently acquired the Twinbrooke Shopping Centre in Fairfax, Virginia, bringing off-market acquisitions to five properties.

In Q3, net income was $50.1 million, and earnings per diluted share were $0.64 for the third quarter of 2021. In the third quarter of 2021, Federal Realty generated an FFO of $118.0 million, or $1.51 per diluted share. Its Board of Trustees also declared a regular quarterly cash dividend of $1.07 per common share, which means an indicated annual rate of $4.28 per common share. The regular common dividend will be payable on January 18, 2022, to common shareholders of record as of January 3, 2022.

Amcor plc (NYSE:AMCR)

Amcor plc (NYSE: AMCR), an Australian company, is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home, and personal care, and other products offering high yield and years of continued dividend growth. 

As of Q3, Amcor plc GAAP shored up net income of $202 million, up 2%, and GAAP earnings per share (EPS) up 4% from 13.1 cents per share. It also showed an adjusted EPS of 17.7 cents per share, up 12% on a comparable constant currency basis, and an adjusted EBIT of $381 million, up 7%. The company also increased returns to shareholders; the quarterly dividend increased to 12 cents per share.

Cardinal Health Inc. (NYSE: CAH)

Cardinal Health Inc. (NYSE: CAH), headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) distributes pharmaceuticals, manufactures, and distributes medical and laboratory products globally and serves as a provider of performance and data solutions for health care facilities.

Cardinal Health Inc. grew revenue 6% versus the prior year to $162 billion and grew non-GAAP EPS and surpassed its enterprise cost savings target for the third consecutive year in Q4 2021.

The company returned nearly $800 million to shareholders through dividends and share repurchases and returned a total of 49 cents per share as a quarterly dividend. The company strengthened its balance sheet by paying down approximately $550 million of long-term debt. 

Archer-Daniels-Midland Co. (NYSE: ADM)

Archer-Daniels-Midland Co. (NYSE: ADM), headquartered in Chicago, focuses on animal and human nutrition and transforms natural products into ingredients and flavors for foods and beverages. The company also works to improve nutrition for pets and livestock with a commitment to sustainable practices.

Archer-Daniels-Midland Co. had Q3 net earnings of $526 million and adjusted net earnings of $548 million, a segment operating profit of $1 billion. It had an adjusted EPS up 9% despite a higher effective tax rate and continued upward growth. 

Archer-Daniels-Midland Co. also offered $1.48 in annual dividends to shareholders.

Boost Your Portfolio with the Aristocrats

The "Aristocrats" — the glitzy name just sounds like companies poised for success, right?

There's a reason. These aptly-named companies show a proven dividend track record and solid, consistent performance. It's no wonder many investors rush to these exact equity income investments to round out their portfolios.

Should you invest $1,000 in 3M right now?

Before you consider 3M, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 3M wasn't on the list.

While 3M currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
3M (MMM)2.7$172.80+0.1%3.43%16.96Hold$188.54
A. O. Smith (AOS)2.8$78.78+2.6%1.42%27.26Hold$76.00
Abbott Laboratories (ABT)2.8$123.82-1.6%1.52%30.72Buy$139.11
AbbVie (ABBV)3.1$132.16+0.1%4.27%31.47Buy$141.42
Aflac (AFL)2.8$61.48+1.0%2.15%9.98Hold$57.40
AT&T (T)2.9$26.34-1.0%7.90%219.52Hold$30.42
Caterpillar (CAT)3.2$214.33+0.1%2.07%22.92Buy$240.00
Chevron (CVX)3.1$127.18+0.2%4.21%24.55Buy$128.33
Coca-Cola (KO)2.8$59.96-0.8%2.80%29.39Buy$62.33
Exxon Mobil (XOM)3.2$72.79+0.9%4.84%-52.37Hold$67.61
International Business Machines (IBM)3.1$128.82-0.4%5.09%24.35Hold$148.50
Johnson & Johnson (JNJ)2.8$162.97-1.2%2.60%24.36Buy$187.40
McDonald's (MCD)3.1$253.61-0.4%2.18%26.15Buy$277.67
NextEra Energy (NEE)2.9$81.92-0.8%1.88%68.27Buy$89.83
PepsiCo (PEP)2.7$173.33-0.5%2.48%29.53Buy$167.31
Procter & Gamble (PG)2.8$161.30-0.8%2.16%29.49Hold$156.00
Target (TGT)3.1$220.58+1.5%1.63%16.23Buy$258.91
Walmart (WMT)2.8$140.20+0.0%1.57%49.02Buy$169.47
West Pharmaceutical Services (WST)2.4$383.52+4.3%0.19%47.58Buy$475.00
Raytheon Technologies (RTX)3.0$88.12+1.0%2.32%40.05Buy$102.20
Carrier Global (CARR)3.1$47.66-0.3%1.26%18.99Hold$56.50
Otis Worldwide (OTIS)2.3$83.23+0.1%1.15%29.51Hold$82.88
Church & Dwight (CHD)2.8$102.42-0.9%0.99%31.42Hold$93.22
Stryker (SYK)3.1$251.92-1.1%1.10%50.69Buy$294.84
Leggett & Platt (LEG)3.4$39.81+2.0%4.22%13.59Buy$55.00
Federal Realty Investment Trust (FRT)2.4$123.02-0.2%3.48%40.60Buy$126.67
Amcor (AMCR)2.5$11.92-0.3%4.03%19.87Hold$13.18
Cardinal Health (CAH)3.6$50.81+0.5%3.86%13.13Hold$56.11
Archer-Daniels-Midland (ADM)2.6$68.59-0.5%2.16%14.81Hold$69.27
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.